Laparoscopy and COVID-19 Contamination
LAPCOV
1 other identifier
observational
20
1 country
4
Brief Summary
The aim of the study is to search the presence of the SARS-COV-2 virus (COVID19) in the pneumoperitoneum of patients with a positive (or suspected) COVID19 status during a routine laparoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2020
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2020
CompletedFirst Posted
Study publicly available on registry
October 29, 2020
CompletedStudy Start
First participant enrolled
November 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedMarch 2, 2021
October 1, 2020
1.1 years
October 23, 2020
February 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The main objective of the study is to demonstrate the presence of SARS-COV-2 in the exsufflated gas at the end of laparoscopy.
The SARS-COV-2 will be looked for in the gas before its elimination at the end of the intervention. To this end, the PCR search will be carried out on the filter used
Day 1 , at the end of the surgery
Secondary Outcomes (1)
The secondary objective of the study is to demonstrate the presence of SARS-COV-2 in the peritoneal fluid during laparoscopy
Day 1 , at the end of the surgery
Interventions
* Swab of the peritoneal fluid for traces of COVID19. The collection of peritoneal fluid is a standard care practice. * Swab from the laparoscopy filter
Eligibility Criteria
Any adult requiring a laparoscopic procedure with a positive or suspected Covid19 status.
You may qualify if:
- Patient of legal age
- Indication for laparoscopy
- Positive (past or current) or suspected Covid19 status (cough, fever, suggestive radiological images, etc.)
- Lack of opposition to participating in the study
You may not qualify if:
- Patient under legal protection
- Covid19 status negative, (former or current) and not suspected
- Patient unable to object
- Patient with no social security care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
AP-HP, Bicêtre Hospital, Anesthesia Department
Le Kremlin-Bicêtre, 94275, France
AP-HP, Bicêtre Hospital, Department of Digestive and Oncological Surgery
Le Kremlin-Bicêtre, 94275, France
AP-HP, Bicêtre Hospital, Gynecology department
Le Kremlin-Bicêtre, 94275, France
AP-HP, Bicêtre Hospital, Urology Department
Le Kremlin-Bicêtre, 94275, France
Biospecimen
Excess peritoneal fluid, usually taken during laparoscopy Exsufflation of the pneumoperitoneum through a filter
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2020
First Posted
October 29, 2020
Study Start
November 19, 2020
Primary Completion
January 1, 2022
Study Completion
January 1, 2022
Last Updated
March 2, 2021
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share